mci 9038 has been researched along with Angiospasm, Intracranial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, H; Nagata, I; Sakai, H; Sakai, N; Xue, JH; Yanamoto, H; Zhang, Z | 1 |
1 other study(ies) available for mci 9038 and Angiospasm, Intracranial
| Article | Year |
|---|---|
Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Topics: Animals; Antithrombins; Arginine; Becaplermin; Benzamidines; Cerebral Arteries; Cisterna Magna; Guanidines; Immunohistochemistry; Injections; Kinetics; Male; Pipecolic Acids; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rabbits; Radiography; Recombinant Proteins; Serine Proteinase Inhibitors; Subarachnoid Hemorrhage; Sulfonamides; Vasospasm, Intracranial | 2001 |